New adjuvanted vaccines in pregnancy: what is known about their safety?

References

• Skowronski DM, De Serres G. Is routine influenza immunization warranted in early pregnancy? Vaccine27(35), 4754–4770 (2009).
   PubMed Web of Science ®Google Scholar
• Mak TK, Mangtani P, Leese J, Watson JM, Pfeifer D. Influenza vaccination in pregnancy: current evidence and selected national policies. Lancet Infect. Dis.8(1), 44–52 (2008).
   PubMed Web of Science ®Google Scholar
• Black SO, Shinefield HR, France EK, Fireman BH, Platt ST, Shay D. Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am J. Perinatol.21(6), 333–339 (2004).
   PubMed Web of Science ®Google Scholar
• Zaman K, Roy E, Arifeen SE et al. Effectiveness of maternal influenza immunization in mothers and infants. N. Engl. J. Med.359(15), 1555–1564 (2008).
   PubMed Web of Science ®Google Scholar
• Ayoub DM, Yazbak FE. A closer look at influenza vaccination during pregnancy. Lancet Infect. Dis.8(11), 660–661 (2008).
   PubMed Web of Science ®Google Scholar
• Naleway AL, Smith WJ, Mullooly JP. Delivering influenza vaccine to pregnant women. Epidemiol. Rev.28(1), 47–53 (2006).
   PubMed Web of Science ®Google Scholar
• Gall SA. Vaccines for pertussis and influenza: recommendations for use in pregnancy. Clin. Obstet. Gynecol.51(3), 486–497 (2008).
   PubMed Web of Science ®Google Scholar
• Mooi FR, de Greeff SC. The case for maternal vaccination against pertussis. Lancet Infect. Dis.7(9), 614–624 (2007).
   PubMed Web of Science ®Google Scholar
• Tsai T, Kyaw MH, Novicki D, Nacci P, Rai S, Clemens R. Exposure to MF59-adjuvanted influenza vaccines during pregnancy – a retrospective analysis. Vaccine28(7), 1877–1880 (2010).
   PubMed Web of Science ®Google Scholar
• Trundley A, Moffett A. Human uterine leukocytes and pregnancy. Tissue Antigens63(1), 1–12 (2004).
   PubMed Web of Science ®Google Scholar
• Veenstra van Nieuwenhoven AL, Bouman A, Moes H et al. Endotoxin-induced cytokine production of monocytes of third-trimester pregnant women compared with women in the follicular phase of the menstrual cycle. Am. J. Obstet. Gynecol.188(4), 1073–1077 (2003).
   PubMed Web of Science ®Google Scholar
• Lala PK, Chakraborty C. Factors regulating trophoblast migration and invasiveness: possible derangements contributing to preeclampsia and fetal injury. Placenta24(6), 575–587 (2003).
   PubMed Web of Science ®Google Scholar
• Wells M. The pathology of gestational trophoblastic disease: recent advances. Pathology39(1), 88–96 (2007).
   PubMed Web of Science ®Google Scholar
• Nagamatsu T, Schust DJ. The immunomodulatory roles of macrophages at the maternal–fetal interface. Reprod. Sci.17(3), 209–218 (2010).
   PubMed Web of Science ®Google Scholar
• Lash GE, Robson SC, Bulmer JN. Review: functional role of uterine natural killer (uNK) cells in human early pregnancy decidua. Placenta31(Suppl.), S87–S92 (2010).
   Google Scholar
• King A. Uterine leukocytes and decidualization. Hum. Reprod. Update6(1), 28–36 (2000).
   PubMed Web of Science ®Google Scholar
• Williams PJ, Searle RF, Robson SC, Innes BA, Bulmer JN. Decidual leucocyte populations in early to late gestation normal human pregnancy. J. Reprod. Immunol.82(1), 24–31 (2009).
   PubMed Web of Science ®Google Scholar
• Starkey PM, Sargent IL, Redman CWG. Cell populations in human early pregnancy decidua: characterization and isolation of large granular lymphocytes by flow cytometry. Immunology65(1), 129–134 (1988).
   PubMed Web of Science ®Google Scholar
• Bulmer JN, Morrison L, Longfellow M, Ritson A, Pace D. Granulated lymphocytes in human endometrium: histochemical and immunohistochemical studies. Hum. Reprod.6(6), 791–798 (1991).
   PubMed Web of Science ®Google Scholar
• Gustafsson C, Mjosberg J, Matussek A et al. Gene expression profiling of human decidual macrophages: evidence for immunosuppressive phenotype. PLoS ONE3(4), e2078 (2008).
   PubMed Web of Science ®Google Scholar
• Craven CM, Morgan T, Ward K. Decidual spiral artery remodelling begins before cellular interaction with cytotrophoblasts. Placenta19(4), 241–252 (1998).
   PubMed Web of Science ®Google Scholar
• Hanna J, Goldman-Wohl D, Hamani Y et al. Decidual NK cells regulate key developmental processes at the human fetal–maternal interface. Nat. Med.12(9), 1065–1074 (2006).
   PubMed Web of Science ®Google Scholar
• Mjosberg J, Berg G, Jenmalm MC, Ernerudh J. FOXP3+ regulatory T cells and T helper 1, T helper 2, and T helper 17 cells in human early pregnancy decidua. Biol. Reprod.82(4), 698–705 (2010).
   PubMed Web of Science ®Google Scholar
• Somerset DA, Zheng Y, Kilby MD, Sansom DM, Drayson MT. Normal human pregnancy is associated with an elevation in the immune suppressive CD25+ CD+ regulatory T-cell subset. Immunology112(1), 38–43 (2004).
   PubMed Web of Science ®Google Scholar
• Tilburgs T, Roelen DL, Van Der Mast BJ et al. Evidence for a selective migration of fetus-specific CD4+CD25bright regulatory T cells from the peripheral blood to the decidua in human pregnancy. J. Immunol.180(8), 5737–5745 (2008).
   PubMed Web of Science ®Google Scholar
• Sasaki Y, Sakai M, Miyazaki S, Higuma S, Shiozaki A, Saito S. Decidual and peripheral blood CD4+CD25+ regulatory T cells in early pregnancy subjects and spontaneous abortion cases. Mol. Hum. Reprod.10(5), 347–353 (2004).
   PubMed Web of Science ®Google Scholar
• Heikkinen J, Mottonen M, Alanen A, Lassila O. Phenotypic characterization of regulatory T cells in the human decidua. Clin. Exp. Immunol.136(2), 373–378 (2004).
   PubMed Web of Science ®Google Scholar
• Aluvihare VR, Betz AG. The role of regulatory T cells in alloantigen tolerance. Immunol. Rev.212, 330–343 (2006).
   PubMed Web of Science ®Google Scholar
• Scholz C, Toth B, Brunnhuber R et al. Glycodelin a induces a tolerogenic phenotype in monocyte-derived dendritic cells in vitro. Am. J. Reprod. Immunol.60(6), 501–512 (2008).
   PubMed Web of Science ®Google Scholar
• Ban YL, Kong BH, Qu X, Yang QF, Ma YY. BDCA-1+, BDCA-2+ and BDCA-3+ dendritic cells in early human pregnancy decidua. Clin. Exp. Immunol.151(3), 399–406 (2008).
   PubMed Web of Science ®Google Scholar
• Askelund K, Liddell HS, Zanderigo AM et al. CD83+ dendritic cells in the decidua of women with recurrent miscarriage and normal pregnancy. Placenta25(2–3), 140–145 (2004).
   PubMed Web of Science ®Google Scholar
• Kammerer U, Schoppet M, McLellan AD et al. Human decidua contains potent immunostimulatory CD83+ dendritic cells. Am. J. Pathol.157(1), 159–169 (2000).
   PubMed Web of Science ®Google Scholar
• Gardner L, Moffett A. Dendritic cells in the human decidua. Biol. Reprod.69(4), 1438–1446 (2003).
   PubMed Web of Science ®Google Scholar
• Miyazaki S, Tsuda H, Sakai M et al. Predominance of Th2-promoting dendritic cells in early human pregnancy decidua. J. Leukoc. Biol.74(4), 514–522 (2003).
   PubMed Web of Science ®Google Scholar
• Veenstra Van Nieuwenhoven AL, Heineman MJ, Faas MM. The immunology of successful pregnancy. Hum. Reprod. Update9(4), 347–357 (2003).
   PubMed Web of Science ®Google Scholar
• Redman CW, Sargent IL. Immunology of preeclampsia. Am. J. Reprod. Immunol.63(6), 534–543 (2010).
   PubMed Web of Science ®Google Scholar
• Mestan K, Yu Y, Matoba N et al. Placental inflammatory response is associated with poor neonatal growth: preterm birth cohort study. Pediatrics125(4), e891–e898 (2010).
   PubMed Web of Science ®Google Scholar
• Sacks GP, Clover LM, Bainbridge DRJ, Redman CWG, Sargent IL. Flow cytometric measurement of intracellular Th1 and Th2 cytokine production by human villous and extravillous cytotrophoblast. Placenta22(6), 550–559 (2001).
   PubMed Web of Science ®Google Scholar
• Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA. Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc. Natl Acad. Sci. USA93(2), 705–708 (1996).
   PubMed Web of Science ®Google Scholar
• Sargent IL. Maternal and fetal immune responses during pregnancy. Exp. Clin. Immunogenet.10(2), 85–102 (1993).
   PubMedGoogle Scholar
• Faas MM, Donker RB, van Pampus MG et al. Plasma of pregnant and preeclamptic women activates monocytes in vitro. Am. J. Obstet. Gynecol.199(1), 84.e1–84.e8 (2008).
   Google Scholar
• Mellembakken JR, Aukrust P, Olafsen MK, Ueland T, Hestdal K, Videm V. Activation of leukocytes during the uteroplacental passage in preeclampsia. Hypertension39(1), 155–160 (2002).
   PubMed Web of Science ®Google Scholar
• Davis D, Kaufmann R, Moticka EJ. Nonspecific immunity in pregnancy: monocyte surface Fcg receptor expression and function. J. Reprod. Immunol.40(2), 119–128 (1998).
   PubMed Web of Science ®Google Scholar
• Naccasha N, Gervasi MT, Chaiworapongsa T et al. Phenotypic and metabolic characteristics of monocytes and granulocytes in normal pregnancy and maternal infection. Am. J. Obstet. Gynecol.185(5), 1118–1123 (2001).
   PubMed Web of Science ®Google Scholar
• Luppi P, Haluszczak C, Betters D, Richard CAH, Trucco M, DeLoia JA. Monocytes are progressively activated in the circulation of pregnant women. J. Leukoc. Biol.72(5), 874–884 (2002).
   PubMed Web of Science ®Google Scholar
• Sacks GP, Studena K, Sargent K, Redman CW. Normal pregnancy and preeclampsia both produce inflammatory changes in peripheral blood leukocytes akin to those of sepsis. Am. J. Obstet. Gynecol.179(1), 80–86 (1998).
   PubMed Web of Science ®Google Scholar
• Luppi P, Haluszczak C, Trucco M, DeLoia JA. Normal pregnancy is associated with peripheral leukocyte activation. Am. J. Reprod. Immunol.47(2), 72–81 (2002).
   PubMed Web of Science ®Google Scholar
• Ueda Y, Hagihara M, Okamoto A et al. Frequencies of dendritic cells (myeloid DC and plasmacytoid DC) and their ratio reduced in pregnant women: comparison with umbilical cord blood and normal healthy adults. Hum. Immunol.64(12), 1144–1151 (2003).
   PubMed Web of Science ®Google Scholar
• Darmochwal-Kolarz D, Rolinski J, Tabarkiewicz J et al. Blood myeloid and lymphoid dendritic cells are stable during the menstrual cycle but deficient during mid-gestation. J. Reprod. Immunol.59(2), 193–203 (2003).
   PubMed Web of Science ®Google Scholar
• Shin S, Jang JY, Roh EY et al. Differences in circulating dendritic cell subtypes in pregnant women, cord blood and healthy adult women. J. Korean Med. Sci.24(5), 853–859 (2009).
   PubMed Web of Science ®Google Scholar
• Miwa N, Hayakawa S, Miyazaki S et al. IDO expression on decidual and peripheral blood dendritic cells and monocytes/macrophages after treatment with CTLA-4 or interferon-γ increase in normal pregnancy but decrease in spontaneous abortion. Mol. Hum. Reprod.11(12), 865–870 (2005).
   PubMed Web of Science ®Google Scholar
• von Rango U, Krusche CA, Beier HM, Classen-Linke I. Indoleamine-dioxygenase is expressed in human decidua at the time maternal tolerance is established. J. Reprod. Immunol.74(1–2), 34–45 (2007).
   PubMed Web of Science ®Google Scholar
• Watanabe M, Iwatani Y, Kaneda T et al. Changes in T, B, and NK lymphocyte subsets during and after normal pregnancy. Am. J. Reprod. Immunol.37(5), 368–377 (1997).
   PubMed Web of Science ®Google Scholar
• Kuhnert M, Strohmeier R, Stegmuller M, Halberstadt E. Changes in lymphocyte subsets during normal pregnancy. Eur. J. Obstet. Gynecol. Reprod. Biol.76(2), 147–151 (1998).
   PubMed Web of Science ®Google Scholar
• Borzychowski AM, Croy BA, Chan WL, Redman CWG, Sargent IL. Changes in systemic type 1 and type 2 immunity in normal pregnancy and preeclampsia may be mediated by natural killer cells. Eur. J. Immunol.35(10), 3054–3063 (2005).
   PubMed Web of Science ®Google Scholar
• Beer AE, Kwak JY, Ruiz JE. Immunophenotypic profiles of peripheral blood lymphocytes in women with recurrent pregnancy losses and in infertile women with multiple failed in vitro fertilization cycles. Am. J. Reprod. Immunol.35(4), 376–382 (1996).
   PubMed Web of Science ®Google Scholar
• Wegmann TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal–fetal relationship: is successful pregnancy a Th2 phenomenon? Immunol. Today14(7), 353–356 (1993).
   PubMedGoogle Scholar
• Saito S, Sakai M, Sasaki Y, Tanebe K, Tsuda H, Michimata T. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin. Exp. Immunol.117(3), 550–555 (1999).
   PubMed Web of Science ®Google Scholar
• Chaouat G, Menu E, Kinsky R, Brezin C. Immunologically mediated abortions: one or several pathways? Res. Immunol.141(2), 188–195 (1990).
   PubMedGoogle Scholar
• Haimovici F, Hill JA, Anderson DJ. The effects of soluble products of activated lymphocytes and macrophages on blastocyst implantation events in vitro. Biol. Reprod.44(1), 69–75 (1991).
   PubMed Web of Science ®Google Scholar
• Saito S, Nakashima A, Shima T, Ito M. Th1/Th2/Th17 and regulatory T-cell paradigm in pregnancy. Am.J. Reprod. Immunol.63(6), 601–610 (2010).
   PubMed Web of Science ®Google Scholar
• Aluvihare VR, Kallikourdis M, Betz AG. Regulatory T cells mediate maternal tolerance to the fetus. Nat. Immunol.5(3), 266–271 (2004).
   PubMed Web of Science ®Google Scholar
• Sasaki Y, Miyazaki S, Sakai M, Saito S. CD4+CD25+ regulatory T cells are increased in the human early pregnancy decidua and have immunosuppressive activity. Am. J. Reprod. Immunol.49, 356 (2003).
   Google Scholar
• Ashkar AA, Di Santo JP, Croy BA. Interferon g contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J. Exp. Med.192(2), 259–270 (2000).
   PubMed Web of Science ®Google Scholar
• Ashkar AA, Black GP, Wei Q et al. Assessment of requirements for IL-15 and IFN regulatory factors in uterine NK cell differentiation and function during pregnancy. J. Immunol.171(6), 2937–2944 (2003).
   PubMed Web of Science ®Google Scholar
• Hering L, Herse F, Verlohren S et al. Trophoblasts reduce the vascular smooth muscle cell proatherogenic response. Hypertension51(2), 554–559 (2008).
   PubMed Web of Science ®Google Scholar
• Zhang JH, He H, Borzychowski AM, Takeda K, Akira S, Croy BA. Analysis of cytokine regulators inducing interferon production by mouse uterine natural killer cells. Biol. Reprod.69(2), 404–411 (2003).
   PubMed Web of Science ®Google Scholar
• Monk JM, Leonard S, McBey BA, Croy BA. Induction of murine spiral artery modification by recombinant human interferon-γ. Placenta26(10), 835–838 (2005).
   PubMed Web of Science ®Google Scholar
• Weinberg ED. Pregnancy-associated depression of cell-mediated immunity. Rev. Infect. Dis.6(6), 814–831 (1984).
   PubMedGoogle Scholar
• Fink CG, Read SJ, Hopkin J, Peto T, Gould S, Kurtz JB. Acute herpes hepatitis in pregnancy. J. Clin. Pathol.46(10), 968–971 (1993).
   PubMed Web of Science ®Google Scholar
• Lagerberg RE. Malaria in Pregnancy: a literature review. J. Midwifery Womens Health53(3), 209–215 (2008).
   PubMed Web of Science ®Google Scholar
• Ostensen M, Aune B, Husby G. Effect of pregnancy and hormonal changes on the activity of rheumatoid arthritis. Scand. J. Rheumatol.12(2), 69–72 (1983).
   PubMed Web of Science ®Google Scholar
• Varner MW. Autoimmune disorders and pregnancy. Semin. Perinatol.15(3), 238–250 (1991).
   PubMed Web of Science ®Google Scholar
• Apitz K. A study on the generalized Shwartzman phenomenon. J. Immunol.29(3), 255–266 (1935).
   Google Scholar
• Theiss W, Beller FK. Exchange transfusion experiments in rats inducing intravascular coagulation. Surg. Gynecol. Obstet.135(5), 713–716 (1972).
   PubMedGoogle Scholar
• Bakker WW, Poelstra K, Timmerman W, Hardonk MJ, Koiter TR, Schuiling GA. Experimental endotoxemia in pregnancy: in situ glomerular microthrombus formation associated with impaired glomerular adenosine diphosphatase activity. J. Lab. Clin. Med.114(5), 531–537 (1989).
   PubMed Web of Science ®Google Scholar
• Bakker WW, Timmerman W, Poelstra K, Schuiling GA. Endotoxin induced intraplacental thrombotic tendency and decreased vascular ADPase in the pregnant rat. Placenta13(3), 281–290 (1992).
   PubMed Web of Science ®Google Scholar
• Visscher CA, Faas MM, Bakker WW, Schuiling GA. Reproductive condition, glomerular adenosine diphosphatase activity, and platelet aggregation in the rat: effect of endotoxin. Biol. Reprod.49(6), 1303–1309 (1993).
   PubMed Web of Science ®Google Scholar
• Faas MM, Schuiling GA, Baller JFW, Visscher CA, Bakker WW. A new animal model for human preeclampsia: ultra-low-dose endotoxin infusion in pregnant rats. Am. J. Obstet. Gynecol.171(1), 158–164 (1994).
   PubMed Web of Science ®Google Scholar
• Faas MM, Schuiling GA, Baller JFW, Bakker WW. Glomerular inflammation in pregnant rats after infusion of low dose endotoxin: an immunohistological study in experimental preeclampsia. Am. J. Pathol.147(5), 1510–1518 (1995).
   PubMed Web of Science ®Google Scholar
• Thompson BS, Chilton PM, Ward JR, Evans JT, Mitchell TC. The low-toxicity versions of LPS, MPL adjuvant and RC529, are efficient adjuvants for CD4+ T cells. J. Leukoc. Biol.78(6), 1273–1280 (2005).
   PubMed Web of Science ®Google Scholar
• Casella CR, Mitchell TC. Putting endotoxin to work for us: monophosphoryl lipid A as a safe and effective vaccine adjuvant. Cell Mol. Life Sci.65(20), 3231–3240 (2008).
   PubMed Web of Science ®Google Scholar
• Faas MM, van der Schaaf G, Borghuis T et al. Extracellular ATP induces albuminuria in pregnant rats. Nephrol. Dial. Transplant.25(8), 2468–2478 (2010).
   PubMed Web of Science ®Google Scholar
• Arad M, Atzil S, Shakhar K, Adoni A, Ben-Eliyahu S. Poly I-C induces early embryo loss in F344 rats: a potential role for NK cells. Am. J. Reprod. Immunol.54(1), 49–53 (2005).
   PubMed Web of Science ®Google Scholar
• Alexander BT, Cockrell KL, Massey MB, Bennett WA, Granger JP. Tumor necrosis factor-a-induced hypertension in pregnant rats results in decreased renal neuronal nitric oxide synthase expression. Am. J. Hypertens.15(2 Pt 1), 170–175 (2002).
   PubMed Web of Science ®Google Scholar
• Athanassakis I, Aifantis Y, Ranella A, Vassiliadis S. Production of embryotoxic IgG antibodies during IFN-g treatment of pregnant mice. Am. J. Reprod. Immunol.36(2), 111–117 (1996).
   PubMed Web of Science ®Google Scholar
• O’Hagan DT, De Gregorio E. The path to a successful vaccine adjuvant – ‘the long and winding road’. Drug Discov. Today14(11–12), 541–551 (2009).
   PubMed Web of Science ®Google Scholar
• Garcon N, Chomez P, Van MM. GlaxoSmithKline adjuvant systems in vaccines: concepts, achievements and perspectives. Expert Rev. Vaccines6(5), 723–739 (2007).
   PubMed Web of Science ®Google Scholar
• Ramon G. Sur l’augmentation anormale de l’antitoxine chez les chevaux producteurs de serum antidiphterique. Bull. Soc. Centr. Med.Vet101, 227–234 (1925).
   Google Scholar
• Glenny AT, Pope CG, Waddington H, Wallace U. Immunological notes: XVII–XXIV. J. Pathol. Bacteriol.29, 31–40 (1926).
   Google Scholar
• Fraser CK, Diener KR, Brown MP, Hayball JD. Improving vaccines by incorporating immunological coadjuvants. Expert Rev. Vaccines6(4), 559–578 (2007).
   PubMed Web of Science ®Google Scholar
• Marrack P, McKee AS, Munks MW. Towards an understanding of the adjuvant action of aluminium. Nat. Rev. Immunol.9(4), 287–293 (2009).
   PubMed Web of Science ®Google Scholar
• De Gregorio E, D’Oro U, Wack A. Immunology of TLR-independent vaccine adjuvants. Curr. Opin. Immunol.21(3), 339–345 (2009).
   PubMed Web of Science ®Google Scholar
• Mills KH. Designer adjuvants for enhancing the efficacy of infectious disease and cancer vaccines based on suppression of regulatory T cell induction. Immunol. Lett.122(2), 108–111 (2009).
   PubMed Web of Science ®Google Scholar
• Dupuis M, Murphy TJ, Higgins D et al. Dendritic cells internalize vaccine adjuvant after intramuscular injection. Cell Immunol.186(1), 18–27 (1998).
   PubMed Web of Science ®Google Scholar
• Lambrecht BN, Kool M, Willart MA, Hammad H. Mechanism of action of clinically approved adjuvants. Curr. Opin. Immunol.21(1), 23–29 (2009).
   PubMed Web of Science ®Google Scholar
• Pulendran B. Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology. Nat. Rev. Immunol.9(10), 741–747 (2009).
   PubMed Web of Science ®Google Scholar
• Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. A family of human receptors structurally related to Drosophila Toll. Proc. Natl Acad. Sci. USA95(2), 588–593 (1998).
   PubMed Web of Science ®Google Scholar
• Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity. Nature388(6640), 394–397 (1997).
   PubMed Web of Science ®Google Scholar
• Seubert A, Monaci E, Pizza M, O’Hagan DT, Wack A. The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells. J. Immunol.180(8), 5402–5412 (2008).
   PubMed Web of Science ®Google Scholar
• Sun HX, Xie Y, Ye YP. ISCOMs and ISCOMATRIX. Vaccine27(33), 4388–4401 (2009).
   PubMed Web of Science ®Google Scholar
• Dupuis M, Denis-Mize K, LaBarbara A et al. Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosis. Eur. J. Immunol.31(10), 2910–2918 (2001).
   PubMed Web of Science ®Google Scholar
• Klinman D. Adjuvant activity of CpG oligodeoxynucleotides. Int. Rev. Immunol.25(3–4), 135–154 (2006).
   PubMed Web of Science ®Google Scholar
• Drane D, Gittleson C, Boyle J, Maraskovsky E. ISCOMATRIX adjuvant for prophylactic and therapeutic vaccines. Expert Rev. Vaccines6(5), 761–772 (2007).
   PubMed Web of Science ®Google Scholar
• Galli G, Medini D, Borgogni E et al. Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels. Proc. Natl Acad. Sci. USA106(10), 3877–3882 (2009).
   PubMed Web of Science ®Google Scholar
• Mosca F, Tritto E, Muzzi A et al. Molecular and cellular signatures of human vaccine adjuvants. Proc. Natl Acad. Sci. USA105(30), 10501–10506 (2008).
   PubMed Web of Science ®Google Scholar
• O’Hagan DT, Wack A, Podda A. MF59 is a safe and potent vaccine adjuvant for flu vaccines in humans: what did we learn during its development? Clin. Pharmacol. Ther.82(6), 740–744 (2007).
   PubMed Web of Science ®Google Scholar
• Singh M, Carlson JR, Briones M et al. A comparison of biodegradable microparticles and MF59 as systemic adjuvants for recombinant gD from HSV-2. Vaccine16(19), 1822–1827 (1998).
   PubMed Web of Science ®Google Scholar
• Baudner BC, Ronconi V, Casini D et al. MF59 emulsion is an effective delivery system for a synthetic TLR4 agonist (E6020). Pharm. Res.26(6), 1477–1485 (2009).
   PubMed Web of Science ®Google Scholar
• Tamma PD, Ault KA, del Rio C, Steinhoff MC, Halsey NA, Omer SB. Safety of influenza vaccination during pregnancy. Am. J. Obstet. Gynecol.201(6), 547–552 (2009).
   PubMed Web of Science ®Google Scholar
• Munoz FM, Greisinger AJ, Wehmanen OA et al. Safety of influenza vaccination during pregnancy. Am. J. Obstet. Gynecol.192(4), 1098–1106 (2005).
   PubMed Web of Science ®Google Scholar
• Silveira CM, Caceres VM, Dutra MG, Lopes-Camelo J, Castilla EE. Safety of tetanus toxoid in pregnant women: a hospital-based case–control study of congenital anomalies. Bull. World Health Organ.73(5), 605–608 (1995).
   PubMed Web of Science ®Google Scholar
• Ryan MA, Seward JF. Pregnancy, birth, and infant health outcomes from the National Smallpox Vaccine in Pregnancy Registry, 2003–2006. Clin. Infect. Dis.46(Suppl. 3), S221–S226 (2008).
   Google Scholar
• Ornoy A, Arnon J, Feingold M, Ben Ishai P. Spontaneous abortions following oral poliovirus vaccination in first trimester. Lancet335(8692), 800 (1990).
   PubMedGoogle Scholar
• Cavalcanti DP, Salomao MA, Lopez-Camelo J, Pessoto MA. Early exposure to yellow fever vaccine during pregnancy. Trop. Med. Int. Health12(7), 833–837 (2007).
   PubMed Web of Science ®Google Scholar
• Ryan MA, Smith TC, Sevick CJ et al. Birth defects among infants born to women who received anthrax vaccine in pregnancy. Am. J. Epidemiol.168(4), 434–442 (2008).
   PubMed Web of Science ®Google Scholar
• Veenstra Van Nieuwenhoven AL, Bouman A, Moes H et al. Cytokine production in natural killer cells and lymphocytes in pregnant women compared with women in the follicular phase of the ovarian cycle. Fertil. Steril.77(5), 1032–1037 (2002).
   PubMed Web of Science ®Google Scholar
• Puig-Barbera J, Diez-Domingo J, Varea AB et al. Effectiveness of MF59-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly. Vaccine25(42), 7313–7321 (2007).
   PubMed Web of Science ®Google Scholar
• Dana A, Buchanan KM, Goss MA et al. Pregnancy outcomes from the pregnancy registry of a human papillomavirus type 6/11/16/18 vaccine. Obstet. Gynecol.114(6), 1170–1178 (2009).
   PubMed Web of Science ®Google Scholar
• Garland SM, Hernandez-Avila M, Wheeler CM et al. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N. Engl. J. Med.356(19), 1928–1943 (2007).
   PubMed Web of Science ®Google Scholar
• Smith-McCune K, Sawaya GF. Update on quadrivalent human papillomavirus vaccination and pregnancy outcomes: is contraception advisable? Obstet. Gynecol.114(6), 1168–1169 (2009).
   PubMed Web of Science ®Google Scholar
• Pentsuk N, Van Der Laan JW. An interspecies comparison of placental antibody transfer: new insights into developmental toxicity testing of monoclonal antibodies. Birth Defects Res. B Dev. Reprod. Toxicol.86(4), 1–17 (2009).
   PubMedGoogle Scholar
• Simister NE. Placental transport of immunoglobulin G. Vaccine21(24), 3365–3369 (2003).
   PubMed Web of Science ®Google Scholar
• Dorosko SM, Ayres SL, Connor RI. Induction of HIV-1 MPR649–684-specific IgA and IgG antibodies in caprine colostrum using a peptide-based vaccine. Vaccine26(42), 5416–5422 (2008).
   PubMed Web of Science ®Google Scholar
• de la Fe C, Assuncao P, Saavedra P, Tola S, Poveda C, Poveda JB. Field trial of two dual vaccines against Mycoplasma agalactiae and Mycoplasma mycoides subsp. mycoides (large colony type) in goats. Vaccine25(12), 2340–2345 (2007).
   PubMed Web of Science ®Google Scholar
• Ito SI, Ishii KJ, Shirota H, Klinman DM. CpG oligodeoxynucleotides improve the survival of pregnant and fetal mice following Listeria monocytogenes infection. Infect. Immun.72(6), 3543–3548 (2004).
   PubMed Web of Science ®Google Scholar
• Heldens JGM, Pouwels HGW, Derks CGG, Van de Zande SMA, Hoeijmakers MJH. The first safe inactivated equine influenza vaccine formulation adjuvanted with ISCOM-matrix that closes the immunity gap. Vaccine27(40), 5530–5537 (2009).
   PubMed Web of Science ®Google Scholar
• Menzies FM, Henriquez FL, Roberts CW. Immunological control of congenital toxoplasmosis in the murine model. Immunol. Lett.115(2), 83–89 (2008).
   PubMed Web of Science ®Google Scholar
• Scott JR, Feldbush TL, Covault JM. A study of maternal lymphoid organs and the progeny following treatment with immunomodulating agents during pregnancy. Clin. Exp. Immunol.30(3), 393–402 (1977).
   PubMed Web of Science ®Google Scholar
• Baylis F. Pregnant women deserve better. Nature465(7299), 689–690 (2010).
   PubMed Web of Science ®Google Scholar
• Banzhoff A, Gasparini R, Laghi-Pasini F et al. MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults. PLoS ONE4(2) e4384 (2009).
   PubMed Web of Science ®Google Scholar
• Luheshi GN. Cytokines and fever. Mechanisms and sites of action. Ann. NY Acad. Sci.856, 83–89 (1998).
   PubMed Web of Science ®Google Scholar
• Aaltonen R, Heikkinen T, Hakala K, Laine K, Alanen A. Transfer of proinflammatory cytokines across term placenta. Obstet. Gynecol.106(4), 802–807 (2005).
   PubMed Web of Science ®Google Scholar
• Winkler M, Rath W. [The role of cytokines in the induction of labor, cervical ripening and rupture of the fetal membranes]. Z. Geburtsh. Neonatol200(Suppl. 1), 1–12 (1996).
   PubMed Web of Science ®Google Scholar
• Hendrickx AG, Makori N, Peterson P. Nonhuman primates: their role in assessing developmental effects of immunomodulatory agents. Hum. Exp. Toxicol.19(4), 219–225 (2000).
   PubMed Web of Science ®Google Scholar